These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12630081)

  • 1. Cytologic appearance of toxic nodular goiter after thyrostatic treatment. A karyometric study.
    Słowińska-Klencka D; Klencki M; Sporny S; Popowicz B; Lewiński A
    Anal Quant Cytol Histol; 2003 Feb; 25(1):39-46. PubMed ID: 12630081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in the size of thyrocyte nuclei in aspirates from nontoxic nodular goiter.
    Klencki M; Słowińska-Klencka D; Sporny S; Lewiński A
    Acta Cytol; 1994; 38(4):524-6. PubMed ID: 8042415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyometric analysis in the cytologic diagnosis of thyroid lesions.
    Słowińska-Klencka D; Klencki M; Sporny S; Lewiński A
    Anal Quant Cytol Histol; 1997 Dec; 19(6):507-13. PubMed ID: 9893905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic nodular goiter and cancer: a compelling case for thyroidectomy.
    Smith JJ; Chen X; Schneider DF; Nookala R; Broome JT; Sippel RS; Chen H; Solorzano CC
    Ann Surg Oncol; 2013 Apr; 20(4):1336-40. PubMed ID: 23108556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size of thyrocyte nuclei in aspirates from follicular adenomas: correlation with patients' ages.
    Slowińska-Klencka D; Klencki M; Sporny S; Lewiński A
    Acta Cytol; 1996; 40(3):414-6. PubMed ID: 8669171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric evaluation of thyrostatic treatment on thyreocytes in nodular goiter on cytologic samples.
    Zeppa P; Lepore M; Palombini L
    Anal Quant Cytol Histol; 2005 Apr; 27(2):118-9. PubMed ID: 15913205
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear segmentation in goitre aspirates.
    Nilsson G
    Acta Pathol Microbiol Scand A; 1979 Jan; 87(1):11-3. PubMed ID: 420001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹³¹I treatment of toxic nodular goiter under combined thyrostatic-thyromimetic medication is at low risk of late hypothyroidism.
    Paghera B; Panarotto MB; Maira G; Magri GC; Bertagna F; Bosio G; Rossini P; De Agostini A; Savelli G; Lucchini S; Giubbini R
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):341-7. PubMed ID: 20639819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psammoma bodies in fine needle aspirates from thyroids containing nontoxic hyperplastic nodular goiters.
    Riazmontazer N; Bedayat G
    Acta Cytol; 1991; 35(5):563-6. PubMed ID: 1927201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved quality of life in hyperthyroidism patients after surgery.
    Bukvic B; Zivaljevic V; Sipetic S; Diklic A; Tausanovic K; Stojanovic D; Stevanovic D; Paunovic I
    J Surg Res; 2015 Feb; 193(2):724-30. PubMed ID: 25167783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grave's disease. Appearance in cytologic smears from fine needle aspirates of the thyroid gland.
    Jayaram G; Singh B; Marwaha RK
    Acta Cytol; 1989; 33(1):36-40. PubMed ID: 2916370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-thyroxine effects on thyreocytes and Hürthle cells in nodular hyperplastic goiter on fine needle aspiration samples. Morphometric evaluation.
    Zeppa P; Ferrara G; Chiacchio R; Fulciniti F; Troncone G; Nappi O; Vetrani A; Palombini L
    Anal Quant Cytol Histol; 1994 Jun; 16(3):189-95. PubMed ID: 7916846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
    Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter.
    Peterson ME
    J Endocrinol; 2014 Nov; 223(2):T97-114. PubMed ID: 25297557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid fine-needle aspiration biopsy: which lesions should be biopsied before 131I therapy?
    Listewnik MH; Birkenfeld B; Chosia M; Elbl B; Piwowarska-Bilska H; Zorga P; Niedziałkowska K
    Ann Acad Med Stetin; 2011; 57(1):54-8. PubMed ID: 22593992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse lipomatosis of thyroid with hyperthyroidism.
    Pradeep PV; Kumar R; Ragavan M; Ramakrishna BA
    J Postgrad Med; 2010; 56(1):35-6. PubMed ID: 20393249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.